MTOR and breast carcinoma: Few studies have looked at the relationship between cellular factors that are common in breast cancers and the mTOR pathway’s genetic variation and breast cancer risk, and subtypes and only a small number of single-nucleotide polymorphisms (SNPs) have been examined [51,52].